Medi-Derm with Lidocaine (capsaicin 0.035 % / lidocaine 2 % / menthol 5 % / methyl salicylate 20 % ) Topical Cream
RxNorm 1422563

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 1422563 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Medi-Derm with Lidocaine (capsaicin 0.035 % / lidocaine 2 % / menthol 5 % / methyl salicylate 20 % ) Topical Cream.

The following semantic concepts and normalized strings are associated with this clinical entity:

SBD
Capsaicin 0.35 mg/ML / lidocaine 20 mg/ML / menthol 50 mg/ML / methyl salicylate 200 mg/ML Topical Cream [Medi-Derm with Lidocaine]
AUI:12368693
View
PSN
Medi-Derm with Lidocaine (capsaicin 0.035 % / lidocaine 2 % / menthol 5 % / methyl salicylate 20 % ) Topical Cream
AUI:6374648
View
SY
Medi-Derm with Lidocaine (capsaicin 0.035 % / lidocaine 2 % / menthol 5 % / methyl salicylate 20 % ) Topical Cream
AUI:5464782
View

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

SBDPrescribable

Semantic Branded Drug (SBD):
Capsaicin 0.35 mg/ML / lidocaine 20 mg/ML / menthol 50 mg/ML / methyl salicylate 200 mg/ML Topical Cream [Medi-Derm with Lidocaine]
(Atom ID: 12368693)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
capsaicin 0.35 MG/ML / lidocaine 20 MG/ML / menthol 50 MG/ML / methyl salicylate 200 MG/ML Topical Cream [Medi-Derm with Lidocaine]
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1422563
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12368693
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SBD
Semantic Branded Drug (Ingredient + Strength + Dose Form + Brand Name)
Source Code
1422563
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Technical Attributes & Logic

RXN AI
{330539} 6387
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{343324} 29787
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{446254} 6750
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{577394} 1992
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AM
{330539} 6387
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{343324} 29787
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{446254} 6750
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{577394} 1992
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AVAILABLE STRENGTH
0.35 MG/ML / 20 MG/ML / 50 MG/ML / 200 MG/ML
Available drug strengths listed in the order of ingredients from the drug
RXN BOSS FROM
{330539} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{343324} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{446254} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{577394} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN HUMAN DRUG
US
Drug available for use in Humans
RXTERM FORM
Cream
The RxTerm dose form name for this drug
PSNPrescribable

Prescribable Name (PSN):
Medi-Derm with Lidocaine (capsaicin 0.035 % / lidocaine 2 % / menthol 5 % / methyl salicylate 20 % ) Topical Cream
(Atom ID: 6374648)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
Medi-Derm with Lidocaine (capsaicin 0.035 % / lidocaine 2 % / menthol 5 % / methyl salicylate 20 % ) Topical Cream
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1422563
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
6374648
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
PSN
Prescribable Name (Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.)
Source Code
1422563
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.
SYPrescribable

Synonym (SY):
Medi-Derm with Lidocaine (capsaicin 0.035 % / lidocaine 2 % / menthol 5 % / methyl salicylate 20 % ) Topical Cream
(Atom ID: 5464782)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
Medi-Derm with Lidocaine (capsaicin 0.035 % / lidocaine 2 % / menthol 5 % / methyl salicylate 20 % ) Topical Cream
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1422563
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
5464782
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SY
Synonym (Synonym of another TTY, given for clarity.)
Source Code
1422563
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.